Response to “Letter to the Editor for ‘Hypertonic Saline Versus Other Intracranial-Pressure-Lowering Agents for Patients with Acute Traumatic Brain Injury: A Systematic Review and Meta-analysis’”-Reference-Cited by-同舟云学术

Response to “Letter to the Editor for ‘Hypertonic Saline Versus Other Intracranial-Pressure-Lowering Agents for Patients with Acute Traumatic Brain Injury: A Systematic Review and Meta-analysis’”

Published:2023-11-13 Issue: Volume: Page:
ISSN:1541-6933
Container-title:Neurocritical Care
language:en
Short-container-title:Neurocrit Care

Author:

Bernhardt Keeley,McClune William,Rowland Matthew J.,Shah Akshay^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine,Neurology (clinical)

Link

https://link.springer.com/content/pdf/10.1007/s12028-023-01876-1.pdf

Reference5 articles.

1. Bernhardt K, McClune W, Rowland MJ, Shah A. Hypertonic saline versus other intracranial-pressure-lowering agents for patients with acute traumatic brain injury: a systematic review and meta-analysis. Neurocrit Care. 2023. https://doi.org/10.1007/s12028-023-01771-9.

2. Seethapathy H, Zhao S, Ouyang T, et al. Severe hyponatremia correction, mortality and central pontine myelinolysis. NEJM Evid. 2023. https://doi.org/10.1056/EVIDoa2300107.

3. Baek SH, Jo YH, Ahn S, et al. Risk of overcorrection in rapid intermittent bolus vs slow continuous infusion therapies of hypertonic saline for patients with symptomatic hyponatremia: the SALSA randomized clinical trial. JAMA Intern Med. 2021;181:81–92.

4. Roquilly A, Moyer JD, Huet O, et al. Effect of continuous infusion of hypertonic saline vs standard care on 6-month neurological outcomes in patients with traumatic brain injury: the COBI randomized clinical trial. JAMA. 2021;325:2056–66.

5. Rowland MJ, Veenith T, Scomparin C, et al. “Sugar or Salt” (SOS) trial protocol summary. J Intensive Care Soc. 2022;23:492.